Clinical Viewpoint
Mucosal healing as an index of colitis activity: Back to histological healing for future indices
Burton I. Korelitz MD,
Corresponding Author
Burton I. Korelitz MD
Division of Gastroenterology, Department of Medicine, Lenox Hill Hospital, New York, New York
Lenox Hill Hospital, 100 East 77th St., 6 Black Hall, New York, NY 10075Search for more papers by this authorBurton I. Korelitz MD,
Corresponding Author
Burton I. Korelitz MD
Division of Gastroenterology, Department of Medicine, Lenox Hill Hospital, New York, New York
Lenox Hill Hospital, 100 East 77th St., 6 Black Hall, New York, NY 10075Search for more papers by this authorNo abstract is available for this article.
REFERENCES
- 1 Rutgeerts P, Vermeire S, Van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut. 2007; 56: 453–455.
- 2 Rubin DT. Utilizing mucosal healing as a treatment goal in ulcerative colitis. Gastroenterol Hepatol. 2009; 11: 771–773.
- 3 Kane S, Lu F, Kornbluth A, et al. Controversies in mucosal healing in ulcerative colitis. Inflamm Bowel Dis. 2009; 15: 796–800.
- 4 Schitzler F, Fidder H, Ferrante M, et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis. 2009; 15: 1295–1301.
- 5 Pineton de Chambrun G, Peyrin-Biroulet L, Lemann M, et al. Clinical implications of mucosal healing for the management of IBD. Gastroenterol Hepatol. 2010; 7: 15–29.
- 6 Truelove SC, Richards WC. Biopsy results in ulcerative colitis. Br Med J. 1956; 1: 1315–1318.
- 7 Dick AP, Grayson MJ. Ulcerative colitis: a follow-up investigation with mucosal biopsy studies. Br Med J. 1961; 1: 160–165.
- 8 Matts SGF. The value of rectal biopsies in the diagnosis of ulcerative colitis. Q J Med. 1961; 30: 393–407.
- 9 Dick AP, Holt LP, Dalton ER. Persistence of mucosal abnormality in ulcerative colitis. Gut. 1966; 7: 355–360.
- 10 Morson BC. Rectal biopsy in inflammatory bowel disease. N Engl J Med. 1972; 287: 1337–1339.
- 11 Korelitz BI, Sommers SC. Differential diagnosis of ulcerative colitis and granulomatous colitis by sigmoidoscopy, rectal biopsy and cell counts of rectal mucosa. Am J Gastroenterol. 1974; 61: 460–469.
- 12 Korelitz BI, Sommers SC. Response to drug therapy in ulcerative colitis. Evaluation by rectal biopsy and histopathological changes. Am J Gastroenterol. 1976; 64: 365–370.
- 13 Riley SA, Mani V, Goodman MJ, et al. Microscopic activity in ulcerative colitis: what does it mean? Gut. 1991; 32: 174–178.
- 14 D'Haens, Van Deventer S, Van Hogezand R, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multi-center trial. Gastroenterology. 1999; 116: 1029–1034.
- 15 Geboes K, Riddell R, Ost A, et al. A reproducible grading scale for histological assessment of inflammation in UC. Gut. 2000; 47: 404–409.
- 16 Korelitz BI, Zlatanic J, Smith MJ, et al. Significance of WBC differential when leukopenia is induced by 6MP for IBD. Gastroenterology. 1997; 113: 1810–1814.
- 17 Korelitz BI, Sommers S. Response to drug therapy in Crohn's disease: evaluation by rectal biopsy and mucosal cell counts. J Clin Gastroenterol. 1984; 6: 123–127.
- 18 Bitton A, Peppercorn MA, Antonioli DA, et al. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology. 2001; 120: 13–20.
